Bimetallic Systems. Part 5. Isonitrile-Platinum(II)- or -Palladium(II)- Bis(diphenylphosphino)methane Complexes including Heterobimetallics with Silver(I), Gold(I), or Rhodium(I)

DOI: 10.1039/DT9840001233

Source and publish data:

Journal of the Chemical Society, Dalton Transactions p. 1233 - 1238 (1984)

Update date:2022-08-04

Topics:

Authors:

Langrick, C. Richard

Pringle, Paul G.

Shaw, Bernard L.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1039/DT9840001233

Treatment of cis- with Bu^tNC gives <(Bu^tNC)2Pt(μ-dppm)2Pt(CNBu^t)2>(4+), isolated as the PF6(1-) salt (dppm = Ph2PCH2PPh2).Treatment of Cl2 (M = Pt or Pd) with two equivalents of Bu^tNC or MeNC gave fluxional, mononuclear isonitrile complexes of type (2+), isolated as their PF6(1-) or BPh4(1-) salts.The palladium salts readily lose the CNR ligands.The unidentate-dppm complexes of type (2+) react with AgPF6, HgCl2, or to give heterobimetallic complexes with μ-dppm ligands, but these were not isolated in a pure state.However, the salts Cl2 (M = Pt or Pd) react with the compounds (R = Me, Bu^t, or p-tolyl) to give the heterobimetallic complexes <(RNC)ClM(μ-dppm)2AgCl>(1+) in high yield.These were isolated as Cl(1-), BPh4(1-), or PF6(1-) salts.The salt t)2(dppm-P)2>Cl2, prepared in situ from Cl2 and Bu^tNC, reacts with <4> or to give <(Bu^tNC)ClPt(μ-dppm)2MCl>Cl (M = Ag or Au).Treatment of Cl2 with CPh)(CNBu^t)> gives <(Bu^tNC)(PhC<*>C)Pt(μ-dppm)2AuCl>Cl.Treatment of <(Bu^tNC)ClPt(μ-dppm)2AgCl>Cl with gives the complex <(Bu^tNC)ClPt(μ-dppm)2RhCl(CO)> and silver chloride in a transmetallation reaction.I.r. and 1H-<31P>, 31P-<1H>, and 195Pt-<1H> n.m.r. data are given and discussed.

Full text of DOI:10.1039/DT9840001233

View Article Online / Journal Homepage / Table of Contents for this issue

View Article Online

Products guided by the article

Product name:[Pt(CNC(CH₃)3)Cl((C₆H₅)2PCH₂P(C₆H₅)2)2RhClCO]⁽¹⁺⁾*RhCl₂(CO)2^(1-)=[Pt(CNC(CH₃)3)Cl((C₆H₅)2PCH₂P(C₆H₅)2)2RhClCO]RhCl₂(CO)2

Cas No:92181-50-5

R&D Labs maybe for 92181-50-5

SAMWON INDUSTRIAL LIMITED

Contact:+86-25-84873444

Address:1108, BLDG B, New Century Plaza, No 1, South Taiping Rd.,
Suzhou Kangrun Pharmaceutical, Inc

Contact:86-512-63912376，63913329

Address:Building 2, No. 2358 ,Chang'an Rd, Wujiang Economic Development Zone Pioneering park, china
Penglai Qianwei Chemical Co., Ltd.

Contact:86-535-3357802

Address:Shahelu (north), Penglai, Shandong, China
Shenzhen HwaGen Pharmaceutical Co., Ltd

website:http://www.rafflespt.com

Contact:+86-752-5538396

Address:Guangdong Huizhou China
Yuan Shi(SuQian)Biotechnology Co.,Ltd

website:http://www.yuanshibio.com

Contact:+86-527-84226672

Address:jiangsu suqian

Relevant to this article

Doi:10.1021/jo01155a010
(1949)
Structure and synthesis of FK409, a novel vasodilation isolated from Streptomyces as a semi-artificial fermentation product

Doi:10.1248/cpb.37.2864
(1989)
Phosphine promoted substituent redistribution reactions of B-chlorocatechol borane: Molecular structures of ClBcat, BrBcat and L·ClBcat (cat = 1,2-O₂C₆H₄; L = PMe₃, PEt₃, PBu^t₃,

Doi:10.1039/b010025k
(2001)
A New Copper Acetate-Bis(oxazoline)-Catalyzed, Enantioselective Henry Reaction

Doi:10.1021/ja0373871
(2003)
Syntheses of 5-aryl-5,8-dihydropyrido[2,3-d]pyrimidine-2,4-diamines

Doi:10.1002/ardp.19843170811
(1984)
5-Isoquinolinesulfonamide derivatives. 1. Synthesis and vasodilatory activity of N-(2-guanidinoethyl)-5-isoquinolinesulfonamide derivatives

Doi:10.1021/jm00121a009
(1989)

Article Doi